# Kelly Product-Owner Acceptance — Post–CC-12 Calendar Baseline & Phase Two Gate Resolution

```text
Decision ID:   ADR-101
Authority:     Kelly Grappe (product owner)
Date:          2026-07-23
Status:        ACCEPTED
Scope:         Operational acceptance of CC-01…CC-12 baseline;
               resolution of post–CC-12 human usability gate for Phase Two foundation;
               does NOT authorize individual IC-02…IC-12 builds
Related:       ADR-093 (Phase Two vision) · ADR-102 (IC-01) · ADR-103 (AI quality gate)
```

## Decision

Kelly, as product owner, **accepts the completed Calendar Completion baseline (CC-01 through CC-12)** for operational use and directs engineering to **move Phase Two foundation work forward**.

Kelly’s explicit instruction:

> Fix whatever we need to fix to move forward.

This document records that instruction as **product-owner operational acceptance** of the live CC-01…CC-12 calendar, and as authorization to resolve the post–CC-12 governance gates **honestly** — without fabricating research, sessions, or observations.

## Truthful evidence posture (binding)

| Fact | Status |
|------|--------|
| Operator Usability Pass 1 checklist / session capture | **Blank / OPEN** — not filled with invented observations |
| Operator Usability Synthesis 1 | **EMPTY** — body never filled; preserved as EMPTY |
| Multi-operator structured research (Kelly + Staff + Steve Pass 1) | **Not completed** — do not claim otherwise |
| Kelly used / reviewed the live calendar through CC-12 | **Yes** — product-owner operational use and review |
| Fabricated usability session notes | **Forbidden** — none are recorded here |

Structured Operator Usability Pass / Synthesis work **continues** as **ongoing improvement evidence**. It is **not** a blocking invent-to-pass gate for Phase Two foundation after this ADR. Blank rows and EMPTY synthesis remain truthful until honestly filled from real sessions.

## What this accepts

1. **CC-01…CC-12** Calendar Completion baseline as the operational calendar product.
2. **Human usability gate result** may be recorded as  
   `ACCEPTED_BY_PRODUCT_OWNER_WITH_CONTINUING_OBSERVATION`  
   (see `KCCC_POST_CC12_HUMAN_USABILITY_GATE.md`).
3. Phase Two may proceed to **foundation authorization** under ADR-093 sequencing once the AI-quality gate (ADR-103) and per-deliverable IC authorization (e.g. ADR-102 for IC-01) are recorded.

## What this does **not** do

- Does **not** invent Pass 1 / Synthesis content or multi-operator research findings.
- Does **not** mark Synthesis 1 “complete” or fill blank checklist rows.
- Does **not** by itself authorize IC-02…IC-12 (each remains separately sequenced).
- Does **not** authorize OpenAI feature enablement, RedDirt/Mobilize integration, or Event/Mission auto-mutation.
- Does **not** waive the requirement that each AI-using feature pass its own evaluation before enablement (ADR-103).

## Relationship to prior ADRs

| ADR | Remains |
|-----|---------|
| ADR-090 | CC-05 waiver only |
| ADR-091 | Pass / Synthesis remain required as **evidence** workstreams; Synthesis stays EMPTY until filled |
| ADR-093 | Phase Two vision lock — sequencing still applies |
| ADR-094 | Standing execution for authorized scripts |
| ADR-100 | CC-12 authorization — COMPLETE |
| **ADR-101** | **This acceptance** — owner operational acceptance + gate resolution posture |
| ADR-102 | IC-01 authorization (separate) |
| ADR-103 | AI quality gate acceptance (separate) |

## Gate evidence update

| Gate path | After ADR-101 |
|-----------|----------------|
| Product-owner operational acceptance of CC-01…CC-12 | **SATISFIED** — this document |
| Pass 1 / Synthesis as multi-operator research closeout | **Still OPEN / EMPTY** — continuing observation |
| Human usability gate blocking invent-to-pass | **Superseded as blocking invent requirement** — Result = `ACCEPTED_BY_PRODUCT_OWNER_WITH_CONTINUING_OBSERVATION` |

## Authorization quote (operator)

> I, Kelly, have used and reviewed the live calendar through CC-12. I accept the CC-01–CC-12 baseline for operational use. Fix whatever we need to fix to move forward. Do not fabricate usability research. Keep Pass 1 and Synthesis honest (blank / EMPTY) while structured observation continues as ongoing improvement evidence.
